FindTrial
Sign In

N/A - NEOREX

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-002195-16-AT
Enrollment
Unknown
Registered
2012-03-27
Start date
2012-04-18
Completion date
Unknown
Last updated
2015-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: Erbitux Product Code: EMD27186 Pharmaceutical Form: Solution for infusion INN or Proposed INN: Cetuximab CAS Number: 205923-56-4 Concentration unit: mg/ml milligram(s)/millilitre Concentr

Sponsors

MUW, Klinik für Mund-, Kiefer-und Gesichtschirurgie
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range 60 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Austria

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026